Accurate results
for patient care
Laboratory medicine and in vitro diagnostics
JCTLM Database: higher-order reference materials, methods and services
Details : C19RMP9 - ID-LC-MS/MS-based reference measurement procedure for the quantification of lamotrigine in human serum and plasma
| Type (acronym) | rmp |
|---|---|
| Type | reference measurement procedure |
| Unique Nomination Number | C19RMP9 |
| Analyte Name | lamotrigine |
| IUPAC IFCC Number | CAS84057-84-1 |
| Method capable of Traceability of Analyte to SI or Defined Procedure | yes |
| Applicable Matrices | human serum and plasma; fresh or frozen |
| Name | ID-LC-MS/MS-based reference measurement procedure for the quantification of lamotrigine in human serum and plasma |
| Organization that developed Validated Method | This reference measurement procedure was developed and validated by the laboratory of Dr. Risch Ostschweiz AG in Buchs SG, Switzerland in collaboration with Roche Diagnostics GmbH in Penzberg, Germany |
| Measurement Techniques Used | Isotope dilution mass spectrometry |
| Quantity | Mass concentration |
| From (0) | 0.6 |
| To (0) | 24 |
| Unit (0) | µg/mL |
| From (1) | 5.2 |
| To (1) | 3.6 |
| Unit (1) | % |
| Level of Confidence (%) | 95% |
| Comments on Uncertainty Range | The lowest expected measurement uncertainty of 5.2 % is at the mass concentration of 0.900 µg/mL. The highest expected measurement uncertainty of 3.6 % is at the mass concentration of 20.0 µg/mL. |
| Peer Reviewed Publication | An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of lamotrigine in human serum and plasma, Taibon J. et al, Clinical Chemisty and Laboratory Medicine 2023 61(11) 1930-1941 |
| Comments to be published via JCTLM DB | This reference measurement procedure was developed and validated by the laboratory of Dr. Risch Ostschweiz AG in Buchs SG, Switzerland in collaboration with Roche Diagnostics GmbH in Penzberg, Germany |
| Hyperlink to Final Report of extent of Equivalence Studies among | A method comparison with the existing JCTLM-listed method C10RMP7, namely NIST method for antiepileptic (lamotrigine) was not possible, as the method is no longer used by NIST. |
| Analyte Category Name | Drugs |
| Measurement principle/technique | Isotope dilution mass spectrometry |